Tania Garfias-Veitl
Overview
Explore the profile of Tania Garfias-Veitl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valentova M, Vatic M, Garfias-Veitl T, Sandek A, Bekfani T, Jankowska E, et al.
Diabetes Res Clin Pract
. 2024 Sep;
217:111864.
PMID: 39304136
Aims: Diabetes mellitus (DM) and heart failure (HF) share vascular, skeletal and metabolic abnormalities that can reduce exercise capacity. We investigated whether exercise capacity differ in patients with type 2...
2.
Kanbay M, Siriopol D, Copur S, Hasbal N, Guldan M, Kalantar-Zadeh K, et al.
Aging Clin Exp Res
. 2024 Sep;
36(1):185.
PMID: 39251484
Background: Sarcopenia, a condition marked by progressive muscle mass and function decline, presents significant challenges in aging populations and those with chronic illnesses. Current standard treatments such as dietary interventions...
3.
von Haehling S, Doehner W, Evertz R, Garfias-Veitl T, Derad C, Diek M, et al.
Eur Heart J
. 2024 Aug;
45(37):3789-3800.
PMID: 39185895
Background And Aims: Evidence is lacking that correcting iron deficiency (ID) has clinically important benefits for patients with heart failure with preserved ejection fraction (HFpEF). Methods: FAIR-HFpEF was a multicentre,...
4.
Kneuer J, Grajek I, Winkler M, Erbe S, Meinecke T, Weiss R, et al.
Circulation
. 2024 Jul;
150(14):1101-1120.
PMID: 39005211
Background: Activation of the immune system contributes to cardiovascular diseases. The role of human-specific long noncoding RNAs in cardioimmunology is poorly understood. Methods: Single-cell sequencing in peripheral blood mononuclear cells...
5.
Evertz R, Diehl C, Godde K, Valentova M, Garfias-Veitl T, Overbeck T, et al.
Sci Rep
. 2023 Sep;
13(1):14861.
PMID: 37684302
Maintaining cancer patients' exercise capacity and therefore patients' ability to live a self-determined life is of huge importance, but little is known about major determinants. We sought to identify determinants...
6.
von Haehling S, Muller-Hennessen M, Garfias-Veitl T, Gossling A, Neumann J, Sorensen N, et al.
Cells
. 2023 Apr;
12(7).
PMID: 37048135
Background: In light of overlapping symptoms, discrimination between non-ST-elevation (NSTE) acute coronary syndrome (ACS) and acute heart failure (HF) is challenging, particularly in patients with equivocal clinical presentation for suspected...
7.
Loncar G, Garfias-Veitl T, Valentova M, Vatic M, Lainscak M, Obradovic D, et al.
Eur J Heart Fail
. 2023 Feb;
25(5):714-723.
PMID: 36781201
Aim: To assess bone status expressed as hip bone mineral density (BMD) in men with heart failure (HF). Methods And Results: A total of 141 male patients with HF underwent...
8.
Evertz R, Godde K, Diehl C, Valentova M, Garfias-Veitl T, Braulke F, et al.
ESC Heart Fail
. 2022 Sep;
10(1):167-176.
PMID: 36178215
Aims: Maintaining quality of life (QoL) in patients with cancer has gathered significant interest, but little is known about its major determinants. We sought to identify determinants of QoL in...
9.
da Fonseca G, Garfias-Veitl T, von Haehling S
Eur J Prev Cardiol
. 2022 Feb;
29(6):968-970.
PMID: 35134156
No abstract available.
10.
Giannitsis E, Garfias-Veitl T, Slagman A, Searle J, Muller C, Blankenberg S, et al.
Cells
. 2022 Jan;
11(2).
PMID: 35053326
Regarding the management of suspected Non-ST-segment-elevation acute coronary syndrome (ACS), the main Biomarker-in-Cardiology (BIC)-8 randomized controlled trial study had reported non-inferiority for the incidence of major adverse cardiac events at...